JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2020ACC: 0000899243-20-006521
Officer· See Remarks
Since Jan 2019
+20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
327.1%
1/31/2020
6.12K→26.11K
Total
Net shares
+20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2020 | A · Award | +20K | — | — | 327.1% | 6.12K | 26.11K |
| Total | +20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported